98 related articles for article (PubMed ID: 23001138)
1. The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?
Dias da Silva D; Carmo H; Silva E
Arch Toxicol; 2013 Jan; 87(1):111-22. PubMed ID: 23001138
[TBL] [Abstract][Full Text] [Related]
2. Combination effects of amphetamines under hyperthermia - the role played by oxidative stress.
da Silva DD; Silva E; Carmo H
J Appl Toxicol; 2014 Jun; 34(6):637-50. PubMed ID: 23765447
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of amphetamine mixtures in primary hepatocytes are severely aggravated under hyperthermic conditions.
Dias da Silva D; Silva E; Carmo H
Toxicol In Vitro; 2013 Sep; 27(6):1670-8. PubMed ID: 23628592
[TBL] [Abstract][Full Text] [Related]
4. Mixtures of 3,4-methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non-cytotoxic concentrations.
da Silva DD; Silva E; Carvalho F; Carmo H
J Appl Toxicol; 2014 Jun; 34(6):618-27. PubMed ID: 23670916
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse.
Hondebrink L; Meulenbelt J; van Kleef RG; van den Berg M; Westerink RH
Neurotoxicology; 2011 Dec; 32(6):823-7. PubMed ID: 21729720
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.
Hondebrink L; Meulenbelt J; Rietjens SJ; Meijer M; Westerink RH
Neurotoxicology; 2012 Mar; 33(2):255-60. PubMed ID: 21996653
[TBL] [Abstract][Full Text] [Related]
7. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
van Nieuwenhuijzen PS; McGregor IS
Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
[TBL] [Abstract][Full Text] [Related]
8. MDMA: interactions with other psychoactive drugs.
Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation.
Jaehne EJ; Salem A; Irvine RJ
Pharmacol Biochem Behav; 2005 Jul; 81(3):485-96. PubMed ID: 15904952
[TBL] [Abstract][Full Text] [Related]
10. Electrochemical oxidation of amphetamine-like drugs and application to electroanalysis of ecstasy in human serum.
Garrido EM; Garrido JM; Milhazes N; Borges F; Oliveira-Brett AM
Bioelectrochemistry; 2010 Aug; 79(1):77-83. PubMed ID: 20051327
[TBL] [Abstract][Full Text] [Related]
11. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
12. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
13. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
14. The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Steinkellner T; Freissmuth M; Sitte HH; Montgomery T
Biol Chem; 2011 Jan; 392(1-2):103-15. PubMed ID: 21194370
[TBL] [Abstract][Full Text] [Related]
15. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
Gibb JW; Stone DM; Stahl DC; Hanson GR
NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
[TBL] [Abstract][Full Text] [Related]
16. Effects of seven drugs of abuse on action potential repolarisation in sheep cardiac Purkinje fibres.
Sheridan RD; Turner SR; Cooper GJ; Tattersall JE
Eur J Pharmacol; 2005 Mar; 511(2-3):99-107. PubMed ID: 15792777
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.
Ikeda R; Igari Y; Fuchigami Y; Wada M; Kuroda N; Nakashima K
Eur J Pharmacol; 2011 Jun; 660(2-3):318-25. PubMed ID: 21497593
[TBL] [Abstract][Full Text] [Related]
18. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
Dias da Silva D; Silva MJ; Moreira P; Martins MJ; Valente MJ; Carvalho F; Bastos ML; Carmo H
Arch Toxicol; 2017 Mar; 91(3):1413-1430. PubMed ID: 27358233
[TBL] [Abstract][Full Text] [Related]
19. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine.
Ketabi-Kiyanvash N; Weiss J; Haefeli WE; Mikus G
Addict Biol; 2003 Dec; 8(4):413-8. PubMed ID: 14690877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
